CPT Codes for PGx Testing: A Billing Guide for Labs and TPAs
Pharmacogenetic (PGx) testing is increasingly central to precision medicine. By analyzing how a patient’s genetic makeup influences drug metabolism, efficacy, and adverse reaction…
-
-
OneOme to Shutdown, Deal a Blow to PGx Industry Momentum
OneOme, a leading name in pharmacogenomics testing and personalized medicine, has announced that it will cease operations by November 14, 2025, citing ongoing…
-
The Three Key Factors Driving the Rise of Preemptive Pharmacogenomics
For years, pharmacogenomics (PGx) was seen as a future promise, a fascinating science that could someday make drug therapy safer and more effective….
-
The Goldilocks Genome: Why Getting the “Just Right” Drug Could Save Lives
What if your next prescription could just as easily harm you, simply because of your genes? That unsettling question sits at the heart…
-
APGxA Interview Series: Dr. Gualberto Ruaño, M.D., Ph.D. — Physician Scientist, Innovator, and Entrepreneur
When you talk to Dr. Gualberto Ruaño, you don’t just hear about science — you hear about purpose. A physician, geneticist, and entrepreneur,…
-
The Pharmacogenomics Technology Market: Trends, Insights, and Opportunities
Grand View Research has just released its latest report on the pharmacogenomics technology market, offering fresh insights into one of the fastest-growing areas…
-
How to Navigate FDA Warnings About Unapproved Pharmacogenomic Claims
Pharmacogenetic testing has emerged as one of the most exciting frontiers in personalized medicine. By analyzing a patient’s genetic makeup, these tests promise…
-
APGxA Company Spotlight: UGenome AI
UGenome AI is a US based biotech software company developing next-generation tools for genomic data interpretation. Co-founded by CEO Zachary S. Brooks, Chief Strategy Office Peter Bannister, and Chief Genomics Officer Dr. Jayden Lee, PharmD, EMBA, the company specializes in secondary and tertiary genomic analysis—transforming raw sequencing data into actionable, repeatable insights.
-
Top 10 Pharmacogenomics Service Platforms for TPAs, Brokers, and Employers
The vendors profiled below deliver a mix of services, from laboratory testing to clinical decision support and pharmacist consultation. Each profile explains what the company does, why employers or TPAs might choose them, and what to verify during due diligence. You’ll also find typical use cases to guide selection and help you align the right PGx solution with your population health priorities.
-
APGxA Thought Leader Interview Series: Wafaa M Rashed, BPharm. MSc., PhD, Founder of PAPERI
It’s a bold vision—and one that highlights both the opportunities and challenges facing Africa in the era of genomics and pharmacogenomics. To understand how policy, ethics, and innovation can come together to shape Africa’s future in precision medicine, APGxA spoke with Dr. Wafaa M. Rashed, founder of PAPERI (Pan-African PGS Education and Research Initiative).
End of content
End of content